Multisite Reproducibility of the Broth Microdilution Method for Susceptibility Testing of Nocardia Species
暂无分享,去创建一个
R. Wallace, | D. Koziol | N. Wengenack | G. Woods | F. Witebsky | P. Conville | G. Hall | D. Warshauer | B. Brown-Elliott | S. Deml | T. Van | C. Knapp | S. Killian | R. Wallace
[1] R. Wallace,,et al. Sulfonamide Resistance in Isolates of Nocardia spp. from a U.S. Multicenter Survey , 2011, Journal of Clinical Microbiology.
[2] R. Wallace,,et al. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes , 2011 .
[3] Theresa L. Smith,et al. Antimicrobial-resistant nocardia isolates, United States, 1995-2004. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] Clsi. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .
[5] A. Zelazny,et al. Analysis of secA1 Gene Sequences for Identification of Nocardia Species , 2006, Journal of Clinical Microbiology.
[6] R. Wallace,,et al. Clinical and Laboratory Features of the Nocardia spp. Based on Current Molecular Taxonomy , 2006, Clinical Microbiology Reviews.
[7] Clinical,et al. Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .
[8] M. Hattori,et al. The complete genomic sequence of Nocardia farcinica IFM 10152. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Said-Fernández,et al. In Vitro and In Vivo Activities of Antimicrobials against Nocardia brasiliensis , 2004, Antimicrobial Agents and Chemotherapy.
[10] S. Dorman,et al. Nocardia veterana as a Pathogen in North American Patients , 2003, Journal of Clinical Microbiology.
[11] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[12] P. Nordmann,et al. Biochemical-Genetic Analysis and Distribution of FAR-1, a Class A β-Lactamase from Nocardia farcinica , 1999, Antimicrobial Agents and Chemotherapy.
[13] R. Wallace,,et al. Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis , 1997, Journal of clinical microbiology.
[14] R. Wallace,,et al. Partial characterization of Nocardia farcinica beta-lactamases , 1993, Antimicrobial Agents and Chemotherapy.
[15] R. Wallace,,et al. Clinical and laboratory features of Nocardia nova , 1991, Journal of clinical microbiology.
[16] R. Wallace,,et al. Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica , 1990, Journal of clinical microbiology.
[17] R. Wallace,,et al. Susceptibility testing of Nocardia species for the clinical laboratory. , 1988, Diagnostic microbiology and infectious disease.
[18] W. K. Johnson,et al. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid. , 1987, The Journal of infectious diseases.
[19] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[20] J. Kenneth McClatchy,et al. Susceptibility Testing of Mycobacteria , 1978 .